Literature DB >> 8790889

Development of a chicken model for studying avian polyomavirus infection.

S D Fitzgerald1, S M Williams, W M Reed.   

Abstract

The purpose of this study was to develop a chicken model for studying the pathogenesis of avian polyomaviral infection. Ninety-two 1-day-old specific-pathogen-free (SPF) chicks were divided into the following three treatment groups: nontreated controls, treated with cyclosporine and treated with cyclophosphamide (CY). All birds were inoculated with polyomavirus; half were orally inoculated and half were inoculated by intraperitoneal (IP) injection. Spontaneous mortality and lesion development consistent with polyomaviral infection in psittacine birds occurred only in the CY-treated, IP-inoculated chicks. Immunohistochemistry confirmed that the intranuclear inclusions found microscopically were associated with polyomaviral antigen. Serology demonstrated postinoculation titers against polyomavirus in several experimental groups. One-day-old SPF chickens appear to be convenient models for investigating the pathogenesis of avian polyomavirus infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8790889

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  3 in total

Review 1.  Polyomaviruses of birds: etiologic agents of inflammatory diseases in a tumor virus family.

Authors:  Reimar Johne; Hermann Müller
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

2.  Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.

Authors:  Marc F Le Mire; Darren S Miller; Wendy K Foster; Christopher J Burrell; Allison R Jilbert
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 3.  Pathogenicity of Avian Polyomaviruses and Prospect of Vaccine Development.

Authors:  Chen-Wei Wang; Yung-Liang Chen; Simon J T Mao; Tzu-Chieh Lin; Ching-Wen Wu; Duangsuda Thongchan; Chi-Young Wang; Hung-Yi Wu
Journal:  Viruses       Date:  2022-09-19       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.